Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Nanobiotix last posted its earnings results on Tuesday, March 31st, 2026. The company reported $-0.45809 earnings per share for the quarter, missing analysts' consensus estimates of $0.3039 by $0.76199. The company had revenue of 3.01 M for the quarter and had revenue of 29.64 M for the year. Nanobiotix has generated $-1 earnings per share over the last year ($-0.5 diluted earnings per share) and currently has a price-to-earnings ratio of -59.69. Nanobiotix has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 2025 | $0.30 | -$0.39 | -0.69 | $24.95 M | $3.01 M |
| 09/30/2025 | Q2 2025 | -$0.25 | -$0.11 | 0.14 | $13.63 M | $26.64 M |
| 04/02/2025 | Q4 2024 | -$0.62 | -$0.98 | -0.36 | N/A | $-16,479,000 |
| 09/18/2024 | Q2 2024 | N/A | -$0.46 | N/A | $23.27 M | $9.29 M |
| 04/24/2024 | Q4 2023 | -$0.83 | -$0.30 | 0.53 | N/A | $32.92 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.80 | N/A | N/A | $3.29 M |
| 04/24/2023 | Q4 2022 | N/A | -$0.88 | N/A | N/A | $3.45 M |
| 09/28/2022 | Q2 2022 | N/A | -$0.76 | N/A | N/A | $1.33 M |
| 04/08/2022 | Q4 2021 | N/A | -$0.48 | N/A | N/A | $1.33 M |
| 09/08/2021 | Q2 2021 | N/A | -$0.88 | N/A | N/A | $1.32 M |
| 04/07/2021 | Q4 2020 | N/A | -$0.47 | N/A | N/A | $877.00 K |
| 06/30/2020 | Q2 2020 | N/A | -$0.91 | N/A | N/A | $1.45 M |
| 12/31/2019 | Q4 2019 | N/A | -$1.21 | N/A | N/A | $718.00 K |
| 06/30/2019 | Q2 2019 | N/A | -$1.15 | N/A | N/A | $1.82 M |
| 12/31/2018 | Q4 2018 | N/A | -$0.92 | N/A | N/A | $1.42 M |
| 06/30/2018 | Q2 2018 | N/A | -$0.64 | N/A | N/A | $2.06 M |
| 12/31/2017 | Q4 2017 | N/A | -$0.74 | N/A | N/A | $1.84 M |
| 06/30/2017 | Q2 2017 | N/A | -$0.76 | N/A | N/A | $1.88 M |
| 12/31/2016 | Q4 2016 | N/A | -$0.76 | N/A | N/A | $2.39 M |
| 06/30/2016 | Q2 2016 | N/A | -$0.68 | N/A | N/A | $3.04 M |
The conference call for Nanobiotix's latest earnings report can be listened to online.
The conference call transcript for Nanobiotix's latest earnings report can be read online.
Nanobiotix (:NBTX) has a recorded annual revenue of $29.64 M.
Nanobiotix (:NBTX) has a recorded net income of $-23,961,000.Nanobiotix has generated $-0.5 earnings per share over the last four quarters.
Nanobiotix (:NBTX) has a price-to-earnings ratio of -59.69 and price/earnings-to-growth ratio is -0.66.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED